Gilead.org.il - Gilead Sciences, Inc.

Provided by Alexa ranking, gilead.org.il has ranked N/A in N/A and 3,845,330 on the world. gilead.org.il reaches roughly 806 users per day and delivers about 24,174 users each month. The domain gilead.org.il uses a Commercial suffix and it's server(s) are located in N/A with the IP number 152.19.134.41 and it is a .org.il domain.

WEBMar 21, 2024 · Our Purpose. Scientific Innovation. We discover, develop and deliver medicines for the world’s most devastating diseases, from viruses to cancer to inflammatory conditions. Access & Health Equity.

List of domain same IP 152.19.134.41

Search Results related to gilead.org.il on Search Engine

Gilead Sciences, Inc.
gilead.com

https://www.gilead.com/

WEBMar 21, 2024 · Our Purpose. Scientific Innovation. We discover, develop and deliver medicines for the world’s most devastating diseases, from viruses to cancer to inflammatory conditions. Access & Health Equity.

DA: 27 PA: 3 MOZ Rank: 46

Gilead - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Gilead

WEBGilead (Arabic: جلعاد, Ǧalʻād or Jalaad) is an Arabic term used to refer to the mountainous land extending north and south of Jabbok. It was used more generally for the entire region east of the Jordan River .

DA: 88 PA: 74 MOZ Rank: 41

About Us | Gilead
gilead.com

https://www.gilead.com/our-company/about-us

WEBAbout Us. At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine.

DA: 12 PA: 22 MOZ Rank: 95

Gilead Sciences - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Gilead_Sciences

WEBGilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

DA: 56 PA: 62 MOZ Rank: 51

Medicines | Gilead
gilead.com

https://www.gilead.com/science-and-medicine/medicines

WEBGilead is committed to helping improve the lives of people around the world by bringing forward medicines that prevent, treat and cure devastating diseases. We currently offer more than 25 therapies in the United States and are rapidly growing our portfolio through internal research and development, as well as collaborations with academic and ...

DA: 12 PA: 10 MOZ Rank: 4

Virology, Oncology and Inflammation Pipeline | Gilead
gilead.com

https://www.gilead.com/science-and-medicine/pipeline

WEBApr 25, 2024 · Learn about the investigational medicines in Gilead's pipeline with the potential to help advance care in COVID-19, HIV, viral hepatitis, cancer and inflammation.

DA: 99 PA: 89 MOZ Rank: 81

Press Releases | Gilead
gilead.com

https://www.gilead.com/news-and-press/press-room/press-releases

WEBFebruary 27, 2024. Gilead Announces Funding Initiative to Support HIV Prevention, Anti-Stigma and Health Equity Efforts for Black Cisgender and Transgender Women and Girls in the U.S. February 26, 2024. U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy® to Treat People with HIV with Suppressed Viral Loads, Pre-existing Resistance.

DA: 92 PA: 52 MOZ Rank: 1

COVID-19 | Gilead
gilead.com

https://www.gilead.com/science-and-medicine/our-therapeutic-areas/virology/covid-19

WEBAs a pioneer and leader in antiviral drug development, Gilead developed the first approved antiviral medicine for the treatment of COVID-19. Building on more than three decades of resources and research, we were able to quickly demonstrate its effectiveness and ramp up production to help reduce the burden of the pandemic.

DA: 16 PA: 45 MOZ Rank: 8

Remdesivir | Gilead
gilead.com

https://www.gilead.com/remdesivir

WEBINDICATION. VEKLURY is indicated for the treatment of COVID-19 in adults and pediatric patients (≥28 days old and weighing ≥3 kg) with positive results of SARS-CoV-2 viral testing, who are: Hospitalized, or. Not hospitalized, have mild-to-moderate COVID-19, and are at high risk for progression to severe COVID-19, including hospitalization or death.

DA: 86 PA: 89 MOZ Rank: 54

Gilead Sciences, Inc. - Investor Relations
gilead.com

https://investors.gilead.com/overview/default.aspx

WEBApr 30, 2024 · Supplementary Information. Earnings Presentation. Summary of Remarks. Prepared Remarks. Recent News. Gilead Sciences to Present at Upcoming Investor Conferences. FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV. Gilead Sciences Announces First Quarter 2024 Financial Results. View all news. Investor …

DA: 24 PA: 96 MOZ Rank: 23

Alexa Rank

GLOBAL RANK

3,845,330

Alexa Reach

0.0000355705

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

806

Monthly Unique Visitors

24,174

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

5,171

Indonesia

4,044

Taiwan

1,315

United Kingdom

1,168

Brazil

1,056

Nigeria

923

Egypt

776

Hong Kong

732

Canada

732

Australia

638

Philippines

457

India

445

Malaysia

438

Spain

363

Germany

353

Mexico

338

France

319

Italy

295

Turkey

271

Iraq

247

Thailand

242

Netherlands

232

Israel

230

Cambodia

191

Algeria

147

Ireland

133

Romania

128

Jordan

118

Poland

114

Ghana

109

Argentina

104

South Africa

Belgium

Czechia

Ukraine

Japan

Morocco

South Korea

Lebanon

Saudi Arabia

Austria

Hungary

Sweden

Singapore

Pakistan

Bangladesh

Denmark

Greece

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa Statistics Graph for gilead.org.il

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra
gilead.org.il	A	IN	3600	Ip: 152.19.134.41
gilead.org.il	MX	IN	3600	Pri: 10 Target: harel.org.il
gilead.org.il	TXT	IN	3600	Txt: v=spf1 mx a ?all Entries_0: v=spf1 mx a ?all
gilead.org.il	SOA	IN	3600	Mname: ns1.afraid.org Rname: dnsadmin.afraid.org Serial: 2405020001 Refresh: 86400 Retry: 7200 Expire: 2419200 Minimum-ttl: 3600
gilead.org.il	NS	IN	3600	Target: ns4.afraid.org
gilead.org.il	NS	IN	3600	Target: ns3.afraid.org
gilead.org.il	NS	IN	3600	Target: ns1.afraid.org
gilead.org.il	NS	IN	3600	Target: ns2.afraid.org

Hosting and Whois Zone

IP	152.19.134.41
Domain infomation	% The data in the WHOIS database of the .il registry is provided % by ISOC-IL for information purposes, and to assist persons in % obtaining information about or related to a domain name % registration record. ISOC-IL does not guarantee its accuracy. % By submitting a WHOIS query, you agree that you will use this % Data only for lawful purposes and that, under no circumstances % will you use this Data to: (1) allow, enable, or otherwise % support the transmission of mass unsolicited, commercial % advertising or solicitations via e-mail (spam); % or (2) enable high volume, automated, electronic processes that % apply to ISOC-IL (or its systems). % ISOC-IL reserves the right to modify these terms at any time. % By submitting this query, you agree to abide by this policy. query: gilead.org.il reg-name: gilead domain: gilead.org.il descr: Har'El Family descr: Aba Hilel Silver Haifa descr: 32694 descr: Israel phone: +972 4 8227605 admin-c: II-NH327-IL tech-c: II-NH327-IL zone-c: II-NH327-IL nserver: ns1.afraid.org nserver: ns2.afraid.org nserver: ns3.afraid.org nserver: ns4.afraid.org validity: N/A DNSSEC: unsigned status: Transfer Locked changed: registrar AT ns.il 19980216 (Assigned) changed: registrar AT ns.il 19980611 (Changed) changed: domain-registrar AT isoc.org.il 20021003 (Changed) changed: domain-registrar AT isoc.org.il 20021003 (Changed) changed: domain-registrar AT isoc.org.il 20021013 (Changed) changed: domain-registrar AT isoc.org.il 20021013 (Changed) changed: domain-registrar AT isoc.org.il 20150419 (Changed) changed: domain-registrar AT isoc.org.il 20150831 (Changed) changed: domain-registrar AT isoc.org.il 20160930 (Changed) person: Nadav Harel address Aba Hilel Silver 52 address Haifa address 32694 address Israel phone: +972 4 8227605 e-mail: nyh AT math.technion.ac.il nic-hdl: II-NH327-IL changed: registrar AT ns.il 19960331 changed: registrar AT ns.il 19980216 registrar name: Israel Internet Association ISOC-IL registrar info: www.isoc.org.il % Rights to the data above are restricted by copyright.